Trading Suspension Due to Capital Reduction
- KOSDAQ Market Division suspended trading of NGeneBio common stocks from 15:46 on April 27, 2026 until market close due to capital reduction
- Basis: KOSDAQ Market Disclosure Regulation Article 37 and same regulation Enforcement Rules Article 18
- Pre-opening after-hours trading on the resumption date is not permitted
ADVERTISEMENT (250px+)
KOSDAQ Filing Information
- Filing: Suspension of Stock Trading (Capital Reduction)
- Company: NGeneBio (354200)
- Submission: KOSDAQ Market Division
- Receipt: 04-27-2026
- Under KRX KOSDAQ Market Division